Viridian Therapeutics, Inc. Common Stock VRDN
$18.66
+1.74%
at last close
Analyst Consensus
- Consensus Rating
- Buy (12 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $37.36
- Implied Upside
- +100.2%
- Price Target Range
- $22.00 – $61.00
- Analysts (12 mo)
- 12
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-22 | RBC CapitalLisa Walter |
Maintains | Outperform | $36 → $38 |
| 2026-08-07 | RBC CapitalLisa Walter |
Maintains | Outperform | $35 → $36 |
| 2026-08-07 | Truist SecuritiesGregory Renza |
Maintains | Buy | $38 → $39 |
| 2026-06-30 | RBC CapitalLisa Walter |
Maintains | Outperform | $34 → $35 |
| 2026-06-30 | Truist SecuritiesGregory Renza |
Maintains | Buy | $35 → $38 |
| 2026-06-30 | WedbushLaura Chico |
Maintains | Outperform | $32 → $43 |
| 2026-06-30 | NeedhamSerge Belanger |
Maintains | Buy | $32 → $34 |
| 2026-06-29 | Wells FargoDerek Archila |
Upgrades | Equal-weight → Overweight | $20 → $31 |
| 2026-06-29 | NeedhamSerge Belanger |
Reiterates | Buy | $32 |
| 2026-05-15 | Evercore ISI GroupManeka Mirchandaney |
Maintains | Outperform | $27 → $26 |
| 2026-05-06 | RBC CapitalLisa Walter |
Maintains | Outperform | $30 → $34 |
| 2026-05-05 | NeedhamSerge Belanger |
Reiterates | Buy | $32 |
| 2026-04-21 | Truist SecuritiesGregory Renza |
Maintains | Buy | $36 → $33 |
| 2026-04-08 | WedbushLaura Chico |
Maintains | Outperform | $37 → $31 |
| 2026-04-07 | Goldman SachsRichard Law |
Maintains | Buy | $36 → $31 |
| 2026-04-07 | RBC CapitalLisa Walter |
Maintains | Outperform | $42 → $30 |
| 2026-04-02 | Evercore ISI GroupManeka Mirchandaney |
Maintains | Outperform | $45 → $32 |
| 2026-03-31 | Goldman SachsRichard Law |
Maintains | Buy | $41 → $36 |
| 2026-03-31 | WedbushLaura Chico |
Maintains | Outperform | $44 → $37 |
| 2026-03-31 | Wells FargoDerek Archila |
Maintains | Equal-weight | $29 → $20 |
| 2026-03-31 | HC Wainwright & Co.Douglas Tsao |
Maintains | Buy | $34 → $22 |
| 2026-03-30 | NeedhamSerge Belanger |
Maintains | Buy | $42 → $32 |
| 2026-03-11 | WedbushLaura Chico |
Reiterates | Outperform | $44 |
| 2026-02-27 | RBC CapitalLisa Walter |
Maintains | Outperform | $45 → $42 |
| 2026-02-04 | NeedhamSerge Belanger |
Reiterates | Buy | $42 |
| 2026-02-03 | Wells FargoDerek Archila |
Maintains | Equal-weight | $26 → $29 |
| 2026-01-08 | Truist SecuritiesGregory Renza |
Maintains | Buy | $41 → $40 |
| 2026-01-07 | UBSMichael Yee |
Initiates coverage on | Buy | $50 |
| 2025-12-23 | NeedhamSerge Belanger |
Maintains | Buy | $34 → $42 |
| 2025-12-10 | WedbushLaura Chico |
Maintains | Outperform | $42 → $47 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $18.66
- Market Cap
- $2.08 billion
- 52-Week Range
- $13.18 – $34.29
- Average Volume
- 1.74 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.